Braintree Takes Cypress To Court Over Generic Suprep
Braintree Laboratories Inc. hit Cypress Pharmaceutical Inc. with a patent suit Tuesday in New York federal court seeking to block Cypress from marketing a generic version of the laxative drug Suprep....To view the full article, register now.
Already a subscriber? Click here to view full article